Fish Oil
Krill

MTHFR is the enzyme failure, while SAH is the toxic sludge that builds up as a result of that failure, both ultimately inhibiting the body’s ability to methylate.

Betaine-Homocysteine Methyltransferase (BHMT) is a zinc-dependent enzyme primarily in the liver and kidney that converts homocysteine and betaine into methionine and dimethylglycine, facilitating homocysteine remethylation.

..

CH3
Methyl Doner

Phospholipids
Phosphatidylcholine

The body modifies triglycerides (TAG) into phospholipids (specifically phosphatidylcholine, or PC) primarily through a pathway that involves removing a fatty acid, introducing a phosphate-containing group, and utilizing methyl donors (choline/betaine/methionine) to complete the structure.

The body converts triglycerides to phospholipids primarily in the liver and cells through a process called de novo phospholipid synthesis (Kennedy pathway), where a specific lipase enzyme removes one fatty acid from a triglyceride (or diglyceride), and a phosphate group (linked to a nitrogenous base like choline) is added.

Vitamin B12 and Folate support the methionine cycle, which is required to create phosphatidylcholine in the liver.

Methyl Donors (Choline, Betaine, Folate): These nutrients provide the necessary CH3 groups to remethylate homocysteine back into methionine, which then regenerates SAM.

Homocysteine Remethylation: Homocysteine must be remethylated to methionine to prevent toxicity and maintain methylation potential. This occurs via two main pathways:

Betaine Pathway (BHMT): Primarily in the liver, betaine (derived from choline) transfers a methyl group directly to homocysteine.

Folate Pathway (MS): 5-methyltetrahydrofolate (5-MTHF, derived from folate) remethylates homocysteine in a vitamin 𝐵12-dependent reaction.

..

Based on studies in experimental models and population genetics, specific MTHFR polymorphisms (primarily C677T) are associated with a survival advantage against malaria, while evidence linking MTHFR variations directly to HIV susceptibility or survival is currently limited or inconclusive.

MTHFR Polymorphisms and Malaria Survival Advantage

The MTHFR C677T/C665T Variant: This mutation, which causes reduced enzyme activity, is highly prevalent in areas historically endemic to malaria, such as the Mediterranean region.

Mechanism of Resistance: Research shows that mild deficiency of the methylenetetrahydrofolate reductase (MTHFR) enzyme provides protection against malaria. In studies, mice with this deficiency survived longer when infected with malaria.

Immune Response: The C677T variant is linked to higher levels of lymphocytes and natural killer (NK) cells in the spleen, aiding in the immune response to malarial infection.

Selection Pressure: The high frequency of this polymorphism is believed to have been maintained by natural selection, acting as a "selection pressure" against malaria, despite the mutation being associated with other health issues (like cardiovascular risks).

..

Docosahexaenoic acid (DHA) is an omega−3 fatty acid that is an important component of the human brain, cerebral cortex, skin, and retina.

It can be synthesized from alpha-linolenic acid or obtained directly from maternal milk (breast milk), fatty fish, fish oil, or algae oil.

Conversion: The human body converts ALA to DHA via a series of desaturation (adding double bonds) and elongation (adding carbons) steps, but this process is inefficient.

N-acetylcysteine (NAC) Protection: NAC acts as a precursor to glutathione (GSH), the primary intracellular antioxidant. It neutralizes ROS generated by DHA oxidation and prevents the depletion of GSH caused by toxic lipid hydroperoxides.

DHA's Dual Role
It is important to note that DHA acts as a "double-edged sword." While DHA-derived mediators (like protectin D1) are protective, DHA-OOH itself is harmful, and DHA supplementation can sometimes increase lipid peroxidation if not accompanied by sufficient antioxidant support.

..

Docosahexaenoic acid (DHA) has shown potential therapeutic benefits in mitigating Benign Prostatic Hyperplasia (BPH) by influencing Dihydrotestosterone (DHT) levels and activity.